|Videos|January 8, 2021
Preventing/Treating C. Difficile: Unmet Needs
Current gaps in the prevention/treatment of C. difficile infections, as highlighted by leading healthcare professionals.
Advertisement
Episodes in this series
Advertisement
Related to this article
In an ECOSPOR III analysis, all-cause hospitalization by week 4 fell to 3.4% with fecal microbiota spores vs 16.1% with placebo in recurrent C difficile infection.
Advertisement
Advertisement
Trending on Contagion Live
1
Ebola Update: DRC Outbreak Tops 10,000 Cases as Kenya, Nigeria Report Spread
2
Measles Update: November 6, 2026
3
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
4
A Closer Look at IDSA/ESCMID 2026 Consensus Statements 6 and 7 on Staphylococcus aureus Bacteremia
5